09:45 EDT Sonnet Biotherapeutics (SONN) Holdings Inc trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONN:
- Sonnet says SON-1010 demonstrates ‘strong safety profile’ in atezolizumab combo
- Sonnet Biotherapeutics Holdings Inc trading halted, news pending
- Sonnet BioTherapeutics Announces New Interim CEO Appointment
- Sonnet BioTherapeutics announces passing of founder, CEO Pankaj Mohan
- Sonnet BioTherapeutics completes first safety review of SON-1010